Skip to main content

Altimmune, Inc 8-K, filed Oct 29, 2026

Altimmune, Inc. (ALT)

8-K 2026-10-29 For: 2026-10-27
View Original
Added on October 29, 2026

About this 8-K

Altimmune, Inc filed this 8-K on October 29, 2026, reporting on events of October 27, 2026.

Altimmune, Inc. drew $10.0 million after achieving clinical and financial milestones, extending its amortization date and interest-only period to June 1, 2028. The company must maintain qualified cash greater than or equal to 60% of outstanding term loan advances. AI summary

Items reported

  • Item 2.03: New debt or off-balance-sheet obligation